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Objective: To examine the anti-hyperglycemic effects of aqueous Lenzites betulina
(L. betulina) extracts on normoglycemic glucose-loaded mice.
Methods: Different doses of aqueous extract from L. betulina were administered to 45
ICR mice (Mus musculus) to determine whether there was an effect of L. betulina extracts
on the blood glucose level of the ICR mice. Aqueous extracts of L. betulina were orally
gavaged to mice using oral glucose tolerance test. A total of ﬁve groups were used to
determine the effect of the fungi on blood glucose of the mice. Group A (positive control)
was given 16.7 mg/kg glimepiride; Group B (negative control) was given distilled water;
Group C (low dosage) was given 200 mg/kg aqueous extract; Group D (mid dosage) was
given 400 mg/kg aqueous extract and Group E (high dosage) was given 800 mg/kg
aqueous extract. Baseline blood glucose value was ﬁrstly acquired before induction of
hyperglycemia through D-glucose, after which another check on blood glucose was made
after 0.5 h. Immediately, after the acquisition of hyperglycemic blood glucose level, the
individual administration of treatments were done. After that, three blood collections were
done spanning 3 h with 1 h interval.
Results: The low dose (200 mg/kg) and the mid dose (400 mg/kg) of L. betulina extracts
were signiﬁcantly different (P < 0.05) from their respective baseline values throughout
the whole experiment with the latter surpassing its baseline value during the 3rd hour. On
the other hand, the high dose (800 mg/kg) during the 1st hour after administration was not
signiﬁcantly different (P > 0.05) from its corresponding baseline value, acting faster than
the positive control (glimepiride), which only became signiﬁcantly different (P < 0.05) at
the 2nd hour.
Conclusions: Aqueous L. betulina extract is able to produce hypoglycemic effects on the
mice with all doses, which are able to normalize blood glucose levels at varying times.1. Introduction
Various species of Lenzites sp. are not only widespread
around Asia, but also well distributed around the world. The
species Lenzites betulina var. ﬂaccida can be found in almost all
parts of the world, while some species, such as Lenzites ves-
pacea, are only found in Asia, Africa and Oceania. Other species
like the Lenzites heteromorpha is native to Europe [1]. InPhilippines, multiple species of Lenzites are identiﬁed to be
present such as Lenzites repanda which can be found in the
islands of Bataan, and Lenzites acuta which can be found in
Cagayan Province [2].
Lenzites spp. have no value as food since it has an extremely
tough exterior [3]. There have been different studies on the various
medicinal uses of Lenzites spp. as scavengers of free radicals,
antimicrobials, anti-oxidant, anti-viral and immunosuppressantity, 2041 Taft Avenue, 0922 Manila, Philippines.
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spp. using three different solvents (ethanol, water and petroleum
ether) was performed. The results showed that phenolic and
steroids were present in the ethanol extract; ﬂavonoids, tannins
and steroids were present in the petroleum ether and only
saponins were present in the aqueous extract [5]. However, there
has been no study yet on the hypoglycemic effects of crude
aqueous extract of Lenzites betulina (L. betulina).
The medicinal herbs have been used increasingly with greater
advocacy for complementary and alternative medicine. Since
then, there is a need for scientiﬁc-based research to ﬁnd out the
exact effects of different herbs and plants within the body. In the
Philippines alone, 57.3% of the population is making use of
herbal medicine to either control or prevent diseases [9,10].
Although herbal medicine has clinical substantiation for
several years, mechanisms of how they provide medicinal
effects are not well described. Since majority of the Philippine
population is classiﬁed under the middle class, not all people
can afford prescription medicine for different diseases and the
use of L. betulina as a control of diabetes can serve as a cheap
and accessible alternative prescription medication. Also, the
value of L. betulina would increase especially in the medical
sector and could possibly pave the way for the discovery and
development of alternative medicine for the treatment of
diabetes. Hence, the present study is aimed to investigate the
hypoglycemic effects of crude aqueous extract of L. betulina.
2. Materials and methods
2.1. Fungi collection and processing
L. betulina was obtained from tree barks in Quezon, Palawan
mostly in sites where kaingin was practiced. Bolos and knives
were utilized for the removal of the mushroom from its attach-
ment to the tree. It was authenticated by Edwin R. Tadiosa,
Museum Researcher II, Botany Division at the National
Museum of the Philippines.
Air-drying was done to prevent deterioration of the sample,
after which the samples were then soaked in methanol for 24 h
twice for the removal of low-molecular-weight compounds. The
residues were extracted with distilled water at 100 C for 6 h,
evaporated to a small volume and subjected to lyophilization in a
vacuum [11]. The mushroom sample was dissolved in distilled
water to obtain a ﬁnal concentration of 100 mg/mL.
2.2. Animal procurement and housing
A total of 45 10-week-old female mice of the ICR strain were
obtained from the Research Institute for Tropical Medicine in
Alabang, Muntinlupa, Philippines. They were housed individu-
ally in standard-sized cages in the animal house of De La Salle
University. All cages were cleaned twice a week and bedded
with autoclaved soft wood shavings. Feeders and water bottles
were cleaned and dried twice a week. Prior to the experiment, all
mice were acclimatized for a period of one week to adjust to a
12 h-light: 12 h-dark cycle at (24 ± 2) C and relative humidity
of 55% ± 10%. During the entire acclimatization and experi-
mental period, food pellets and distilled water were supplied ad
libitum. Proper handling and maintenance of the mice were
observed and the Institutional Animal Care and Use Committee
of De La Salle University approved the experimental protocol
used.2.3. Experimental procedures
Baseline blood glucose values were obtained through tail-tip
nicking using an EasyTouch® GCU and immediately after, D-
glucose solution (5 mg/kg body weight) was administered to all
the mice to induce hyperglycemia. About 30 min after the in-
duction of glucose, blood testing was performed to conﬁrm
hyperglycemia.
The mice were divided into 5 groups with 6 mice each. All
treatments (glimepiride and L. betulina extracts) were diluted in
distilled water. Then, Group A (positive control) was given
glimepiride (16.7 mg/kg body weight); Group B (negative con-
trol) was given 0.2 mL of distilled water; Group C–E was given
L. betulina at different concentrations (low dose: 200 mg/kg
body weight; mid dose: 400 mg/kg body weight; high dose:
800 mg/kg body weight). Three more blood collections at 1st,
2nd and 3rd hour post-glucose administration were performed.
2.4. Statistical analysis
The differences in blood glucose levels (mean ± SD) were
analyzed using repeated measures ANOVA and multivariate
ANOVA and means were compared using Tukey's test and
SPSS version 22 to determine signiﬁcant differences among the
treatment groups at P < 0.05.
3. Results
A total of 45 ICR mice were administered with three different
doses of L. betulina extract (200 mg/kg, 400 mg/kg, 800 mg/kg),
and glimepiride was given in the positive control (16.7 mg/kg)
and distilled water was given in the negative control. A total of 5
blood collections were done to quantify blood glucose levels
(mg/dL) during 3 h (Table 1).
Prior to the induction of hyperglycemia to all mice, post hoc
tests showed that there were no signiﬁcant differences between
the baseline levels of all groups. This was supported by the fact
that all groups were subjected to the same conditions. The values
obtained were also within the limit of the normal blood glucose
level (160 mg/dL) [12]. This indicated that no hyperglycemic
activity was present before the administration of any substance
to the mice (Table 1).
After 30 min, the blood glucose values were again compared
after the induction of hyperglycemia to all mice. While all
groups exhibited the desired hyperglycemic condition and no
signiﬁcant differences were observed across all groups (Table 1).
During the 1st hour, the blood glucose level of the negative
control was signiﬁcantly higher from all the other groups sur-
passing the hypoglycemic effect of glimepiride. This indicated
that the mushroom extract exhibited anti-hyperglycemic activity.
Also, within the treated groups, the values from the high dose
group were proved to be signiﬁcantly lower than those from the
low and mid dose groups, including the positive control
(Table 1). This indicated that the mushroom extract at high
levels provided hypoglycemic activity along with the natural
ability of the mice to retain its normal blood glucose level.
After 2 h of baseline testing, continuous decrease in blood
glucose levels for all groups was observed. This time, the high
dose and the positive control groups were not signiﬁcantly
different from each other and glimepiride had the same effect
with the high dose of the L. betulina extract. Both mid dose and
Table 1
Blood glucose level of mice in different treatments.
Groups Baseline 0.5 h 1 h 2 h 3 h
Positive control
(glimepiride, 16.7 mg/kg)
123.778 ± 11.7242,a 189.667 ± 28.4821,a 174.000 ± 16.8151,b 82.333 ± 8.8323,a 66.667 ± 12.7484,a
Negative control (distilled
water)
129.889 ± 17.8574,a 184.889 ± 30.1471,a 204.778 ± 31.0921,c 175.222 ± 22.5712,c 158.667 ± 12.1553,d
Low dose (200 mg/kg) 130.111 ± 12.8883,4,a 187.000 ± 17.8191,a 165.444 ± 19.4242,b 147.444 ± 15.1913,b 140.444 ± 13.0304,c
Mid dose (400 mg/kg) 126.111 ± 13.7343,a 192.889 ± 19.4771,a 161.778 ± 14.3942,b 140.889 ± 12.9463,b 118.778 ± 5.3103,b
High dose (800 mg/kg) 122.000 ± 7.4672,a 216.000 ± 52.2351,a 132.111 ± 12.7912,a 97.778 ± 5.0693,a 78.000 ± 6.7274,a
All the values were expressed as means ± SD. The different superscript letters within the same column were signiﬁcantly different at P < 0.05; The
different superscript numbers within the same row were signiﬁcantly different at P < 0.05.
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other, but they still were signiﬁcantly different with the positive
and high dose groups. This means that after 1.5 h of adminis-
tration of the mushroom extracts, only the high dose group was
able to reach the same hypoglycemic effect as the glimepiride
(Table 1).
At the 3rd hour of testing, blood glucose levels of all mice
continued to decline. Still, only the high dose group was not
signiﬁcantly different from the positive control. The difference
of this time showed that all Lenzites groups were signiﬁcantly
different from each other with the highest dosage exhibiting the
highest hypoglycemic activity followed by the mid and low dose
groups (Table 1). It was noted that the positive control group had
the overall lowest blood glucose level at the end of the treatment.
Throughout the whole test, apart from baseline and when D-
glucose was administered, the negative control group was
constantly signiﬁcantly different from all the other groups
(Table 1). The negative control group was utilized to show the
normalization of the blood glucose levels of the mice during the
whole treatment to guarantee that the varying decrease of blood
glucose for the mice was mainly because of the mushroom
extract. Based from the results, the negative control group
consistently held the highest blood glucose levels among all
groups after the induction of hyperglycemia. Since the blood
glucose levels in the negative control was signiﬁcantly higher
than the positive control and treatment groups, the decrease in
blood glucose levels in all treatment groups was attributed to the
hypoglycemic effects of the L. betulina extract.
Comparing the positive control, low dose, mid dose and high
dose groups' blood glucose levels in the 3rd hour with their
respective baseline values, different results were illustrated.
Theoretically, among all groups, in 0.5 h, where the adminis-
tration of the D-glucose was initiated, it was signiﬁcantly
different with its corresponding baseline blood glucose level as
well as being the highest value across all time intervals since
deliberate induction of hyperglycemia was done.
For the positive control group within the time intervals, it
showed that during the 1st hour, the blood glucose level
decreased, but it did not reach or surpass the baseline blood
glucose value. It was only until the 2nd hour when a signiﬁcant
difference in blood glucose was noted which was observed up
until the ﬁnal hour of experimentation (Table 1).
With the low dose group, in 2nd hour from the administration
of the mushroom extract, it showed a gradual decrease in blood
glucose that blood values were not signiﬁcantly different from
the baseline only after the ﬁnal hour of testing even though the
values didn't go below the baseline. This signiﬁed that the low
dose decreased the blood glucose level up to the normal baselinelevels (Table 1). The same observations with the low dose group
were seen for the mid dose except that during the ﬁnal hour of
testing, the blood glucose level was lower than the baseline.
The high dose group in 30 min after giving of the extract was
already at level with the baseline values and this continued up
until the ﬁnal hour of administration. This was an indication that
the higher dose had a faster hypoglycemic effect compared with
the lower doses. Using the observations described above, we
deduced that as the dose of mushroom extract increased, the time
of onset of the hypoglycemic activity decreased (Table 1).
4. Discussion
This study showed that there was an anti-hyperglycemic ef-
fect on normoglycemic glucose-loaded mice after treatment with
L. betulina. This effect can be attributed to saponins found in
aqueous extracts of L. betulina [5].
Saponins are heterosides due to the presence of one or more
sugars in their structures. Saponins are constitutive triterpenoid,
steroid or steroidal glycoalkaloid molecules and are important in
plant defense against microbial infection as well as possessing
emulsifying properties [13]. It was studied that saponins can
exhibit antidiabetic properties through modulation of calcium
channels and beta cell invigoration. The role of calcium in the
regulation of insulin was proven by the fact that nifedipine, a
calcium channel blocker, signiﬁcantly decreased the insulin
levels when activated. Along with that, the secretion of
insulin was halted once there were no extracellular Ca2+
presence [14].
A study was done by Singh et al. who used triterpenoid
saponin isolated from the leaves of Primula denticulate Sm.
through chromatography and it was then identiﬁed with the use
of nuclear magnetic resonance, UV and infrared ray spectro-
scopic methods [15]. It was administered to streptozotocin
induced diabetic rats along with aqueous and ethanol extracts
from the same plant. Results showed that it was able to lower
the blood glucose level as well as restore the insulin level of
the mice due to triterpenoid can stimulate insulin secretion by
the pancreas.
Saponins from the ethanol extract of Momordica cymbalaria
were given to streptozotocin-nicotinamide induced type 2 dia-
betic mice. Blood glucose, cholesterol, triglycerides and insulin
levels as well as the histopathology of the pancreas were
assessed. The results demonstrated that the saponin extract was
able to lower the blood glucose, cholesterol and triglycerides,
and increase the serum insulin values. This is attributed to the
result of the assessment of the pancreas, in which there was an
increase in beta cells and pancreatic islets [16].
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through stimulation of 5-adenosine monophosphate activated
protein kinase and the insulin receptor/insulin receptor substrate
1/phosphatidylinositol 30-kinase/Akt signaling pathways as well
as increasing the activities of hexokinase and pyruvate kinase,
key enzymes in glucose metabolism speciﬁcally glucose catab-
olism. Adenosine monophosphate activated protein kinase sig-
nals to stimulate glucose uptake in skeletal muscles and reduce
hepatic glucose production and fatty acid oxidation in adipose
tissues [17]. Triterpenoid saponins were extracted from Stauntonia
chinensis and were tested on human HepG2 cells. The results
showed that the extract was able to boost glucose uptake and
insulin sensitivity through the aforementioned mechanisms [18].
This study demonstrated that L. betulina extract was able
to lower the blood glucose levels of ICR mice. Signiﬁcant
difference was observed between the three concentrations as
well as compared to the positive control. During the 1st hour,
the group given the highest dose was the sole group to pro-
duce a signiﬁcant drop in blood glucose. For the 2nd hour,
the positive control was able to achieve the same concentra-
tion as the high dose group, though all groups demonstrated
steady hypoglycemic effects. During the last hour, all mush-
room extract groups were signiﬁcantly different from each
other. The high dose group (800 mg/kg) exhibited a much
faster reaction in relation to hypoglycemic activity compared
to the other two mushroom extract groups. The rate of acti-
vation of the hypoglycemic effect was indirectly proportional
to the dose of the extract given and it was able to surpass the
effect of the positive control during the 1st hour of admin-
istration and became equaled at the end of the experiment.
With this, it was deemed as the most effective dosage of the
mushroom extract. Compounds such as saponins could have
contributed to the anti-hyperglycemic effect of the plant. Less
powerful effects were noted from the low and mid dose,
which indicated that the strength of the antidiabetic property
of L. betulina extract was dose-dependent and the plant could
be used to be an alternative to most ﬁrst generation
sulfonylureas.
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